Mankind Pharma Shares Rise 8% on Q2 Profit Growth to Rs 716 Crore
Mankind Pharma shares surged nearly 8% following a 38% year-on-year increase in Q2 profit, reaching Rs 716 crore. The company's revenue grew by 17%, driven by both domestic and export markets. Additionally, EBITDA margins improved by 210 basis points, reflecting stronger operational performance in the quarter.
ET Markets·



